MGH Center for Women's Mental Health

About MGH Center for Women's Mental Health

This author has not yet filled in any details.
So far MGH Center for Women's Mental Health has created 1460 blog entries.

Weekly Roundup for AUGUST 9, 2019: Recent Publications in Women’s Mental Health

Opioid use in pregnant women is a significant public health concern.  A recent study observed that one out of five pregnant women (21.6%) filled a prescription for an opioid and 2.5% received a chronic opioid [...]

By |2019-08-11T17:01:50-04:00August 10th, 2019|Weekly Roundup|Comments Off on Weekly Roundup for AUGUST 9, 2019: Recent Publications in Women’s Mental Health

Bioidentical, Compounded Hormones Commonly Used by Perimenopausal Women, But No Consistency

Increasing numbers of peri- and post-menopausal women request “bioidentical” rather than synthetic hormones.  Although there is a tendency to think of bioidentical hormones as “all-natural”, they, like synthetic hormones, are manufactured in the laboratory.  In [...]

By |2021-11-04T08:20:41-04:00July 29th, 2019|Hormone Therapy, Menopausal Symptoms, Treatment|Comments Off on Bioidentical, Compounded Hormones Commonly Used by Perimenopausal Women, But No Consistency

Weekly Roundup for JULY 26, 2019: Recent Publications in Women’s Mental Health

We have recently seen an increased interest in the subject of perinatal anxiety.  While we have focused more on depressive symptoms, anxiety symptoms are actually very common during pregnancy and the postpartum period.  According to [...]

By |2020-01-06T16:27:31-04:00July 28th, 2019|Weekly Roundup|Comments Off on Weekly Roundup for JULY 26, 2019: Recent Publications in Women’s Mental Health

Opioid Exposure During Pregnancy, Long-Term Effects on Children’s Development

According to a recent analysis of national data by the Centers for Disease Control, the number of pregnant women with opioid use disorder (as documented at the time of delivery) more than quadrupled from 1999 [...]

By |2019-07-10T13:38:26-04:00July 22nd, 2019|Neurodevelopmental Disorders, Opioids, Outcomes, Perinatal Substance Use|Comments Off on Opioid Exposure During Pregnancy, Long-Term Effects on Children’s Development

Weekly Roundup for JULY 19, 2019: Recent Publications in Women’s Mental Health

This Week in Women's Mental Health Another busy week.  There are several interesting articles which look at non-pharmacological treatment of perinatal mood and anxiety disorders.  Yoga and other complementary treatments show promise but the [...]

By |2019-07-29T11:52:34-04:00July 21st, 2019|Weekly Roundup|Comments Off on Weekly Roundup for JULY 19, 2019: Recent Publications in Women’s Mental Health

Antidepressants Reduce Risk of Depression During Pregnancy, Individualized Treatment Essential

For women with histories of major depression, choosing whether to maintain or to discontinue treatment with an antidepressant during pregnancy is often challenging.  This is a process which requires careful and thoughtful consideration, weighing the [...]

By |2019-07-21T17:49:42-04:00July 17th, 2019|Pregnancy & Medications|Comments Off on Antidepressants Reduce Risk of Depression During Pregnancy, Individualized Treatment Essential

In Brief: FDA Approves New Drug to Improve Sexual Desire in Women

The Food and Drug Administration (FDA) has approved a new drug for the treatment of hypoactive sexual desire disorder in premenopausal women.  Bremelanotide (to be marketed as Vyleesi) is used on-demand. Bremelanotide is a peptide [...]

By |2019-07-10T12:01:16-04:00July 16th, 2019|General, Sexual Health|Comments Off on In Brief: FDA Approves New Drug to Improve Sexual Desire in Women

Weekly Roundup for JULY 12, 2019: Recent Publications in Women’s Mental Health

Although there are data to support the use of many different antidepressants and other psychotropic medications, many women and their providers would prefer to avoid the use of medications during pregnancy.  Options for non-pharmacologic treatment [...]

By |2019-07-15T16:53:06-04:00July 13th, 2019|Weekly Roundup|Comments Off on Weekly Roundup for JULY 12, 2019: Recent Publications in Women’s Mental Health

Brexanolone (Zulresso) for Postpartum Depression Cleared by the DEA, Now Available

Brexanolone, to be marketed by Sage Therapeutics as Zulresso, was initially approved in March 2019, as a treatment for postpartum depression.  At that time, we were told that Zulresso would be available in June 2019. [...]

By |2020-01-05T14:34:41-04:00July 11th, 2019|Medication, Postpartum Depression, Postpartum Psychiatric Disorders, Treatment|Comments Off on Brexanolone (Zulresso) for Postpartum Depression Cleared by the DEA, Now Available
Go to Top